Background and purpose: The thiourea derivative KB-R7943, originally developed as inhibitor of the plasma membrane Na þ /Ca 2 þ exchanger, has been shown to protect against myocardial ischemia-reperfusion injury. We have studied here its effects on mitochondrial Ca 2 þ fluxes. Experimental approach. [Ca 2 þ ] in cytosol, mitochondria and endoplasmic reticulum (ER), and mitochondrial membrane potential were monitored using both luminescent (targeted aequorins) and fluorescent (fura-2, tetramethylrhodamine ethyl ester) probes in HeLa cells. Key results: KB-R7943 was also a potent inhibitor of the mitochondrial Ca 2 þ uniporter (MCU). In permeabilized HeLa cells, KB-R7943 inhibited mitochondrial Ca 2 þ uptake with a Ki of 5.571.3 mM (mean7S.D.). In intact cells, 10mM KB-R7943 reduced by 80% the mitochondrial [Ca 2 þ ] peak induced by histamine. KB-R7943 did not modify the mitochondrial membrane potential and had no effect on the mitochondrial Na þ /Ca 2 þ exchanger. KB-R7943 inhibited histamine-induced ER-Ca 2 þ release in intact cells, but not in cells loaded with a Ca 2 þ -chelator to damp cytosolic [Ca 2 þ ] changes. Therefore, inhibition of ER-Ca 2 þ -release by KB-R7943 was probably due to the increased feedback Ca 2 þ -inhibition of inositol 1,4,5-trisphosphate receptors after MCU block. This mechanism also explains why KB-R7943 reversibly blocked histamine-induced cytosolic [Ca 2 þ ] oscillations in the same range of concentrations required to inhibit MCU. Conclusions and Implications: Inhibition of MCU by KB-R7943 may contribute to its cardioprotective activity by preventing mitochondrial Ca 2 þ -overload during ischemia-reperfusion. In addition, the effects of KB-R7943 on Ca 2 þ homeostasis provide new evidence for the role of mitochondria modulating Ca 2 þ -release and regenerative Ca 2 þ -oscillations. Search for permeable and selective MCU inhibitors may yield useful pharmacological tools in the future.
Introduction
During cell activation, cytosolic [Ca 2 þ ] ([Ca 2 þ ] c ) rises and activates the mitochondrial Ca 2 þ uniporter (MCU). This is a selective Ca 2 þ channel, which transports and accumulates Ca 2 þ in mitochondria, driven by the large electrical potential difference between the cytosol and the mitochondrial matrix. MCU is a highly elusive channel from the molecular point of view, as it has neither been cloned nor isolated yet, and its activity has only been measured by monitoring Ca 2 þ transport into mitochondria (Rizzuto et al., 1994; Bernardi, 1999) or more recently by patch-clamping of mitoplasts (Kirichok et al., 2004) . The activity of MCU is important, first, to determine the rate of Ca 2 þ entry into mitochondria and thus the mitochondrial [
It has been shown that the increase in [Ca 2 þ ] M activates mitochondrial oxidative processes leading to increased NADH and ATP production (Jouaville et al., 1999; Rutter and Rizzuto, 2000) . On the other hand, mitochondrial Ca 2 þ overload may lead to opening of the permeability transition pore and induce necrosis or apoptosis (Bernardi et al., 2001; Hajnoczky et al., 2003; Rizzuto et al., 2003) , a process which has important pathological implications. There is evidence, for example, that this process occurs after heart or brain ischemia and reperfusion and is a major mediator of the subsequent cellular injury and death (for reviews see Halestrap, 2006; Di Lisa and Bernardi, 2006; Vercesi et al., 2006) . In addition, in the last decade, increasing evidence has pointed to the role of mitochondria as a modulator of cytosolic Ca 2 þ signalling (Babcock et al., 1997; Giovannucci et al., 1999; Duchen, 2000; Montero et al., 2000; Rizzuto et al., 2000) . This role is fulfilled mainly through the activity of MCU for Ca 2 þ uptake into mitochondria, and the mitochondrial Na þ /Ca 2 þ exchange (NCX) for Ca 2 þ exit from mitochondria (see Bernardi, 1999) , although the permeability transition pore may also play a role under certain conditions (Ichas et al., 1997) . MCU is closed under resting conditions and becomes activated when [Ca 2 þ ] c rises to the micromolar range. This low-Ca 2 þ affinity implies that mitochondrial Ca 2 þ uptake is effective in modulating the local high-Ca 2 þ microdomains that trigger most of the physiological effects of Ca 2 þ signalling (Berridge et al., 2003) . For example, mitochondria have been shown to modulate catecholamine secretion in chromaffin cells (Giovannucci et al., 1999; Montero et al., 2000) , the Ca 2 þ -dependence of voltage-dependent Ca 2 þ channels (Hernán-dez-Guijo et al., 2001) and capacitative Ca 2 þ channels (Hoth et al., 2000) , the rate of cytosolic Ca 2 þ waves (Boitier et al., 1999) , and the dynamics of [Ca 2 þ ] c oscillations (Collins et al., 2000; Hernández-SanMiguel et al., 2006; Vay et al., 2007) . KB-R7943 was developed 10 years ago as a selective plasma membrane NCX inhibitor (Iwamoto et al., 1996) , and was the starting compound of a family of NCX inhibitors, which have been shown to protect against myocardial ischemiareperfusion injury (Matsuda et al., 2001; Iwamoto, 2004; Iwamoto and Kita, 2004; Hagihara et al., 2005; Matsunaga et al., 2005) . We show here that KB-R7943 is also a potent MCU inhibitor, an effect which could contribute to its cardioprotective activity. In addition, given that HeLa cells lack any detectable plasma membrane NCX activity (Furman et al., 1993; Low et al., 1993) 
Methods
Cell culture and targeted aequorin expression HeLa cells were grown in Dulbecco's-modified Eagle's medium supplemented with 10% fetal calf serum, 50 IU ml À1 penicillin and 50 IU ml À1 streptomycin. The HeLa cell clone MM5, which stably expresses mitochondrially targeted mutated aequorin has been described previously (Montero et al., 2002) . The constructs for aequorin targeted to the cytosol and mutated aequorin targeted to either the endoplasmic reticulum (ER) or the mitochondria have been also described previously (Montero et al., 1995 (Montero et al., , 2000 . Transfections were carried out using Metafectene (Biontex, Munich, Germany).
[ was reduced by incubating the cells for 10 min at 371C with the sarcoplasmic and ER Ca 2 þ -ATPase inhibitor 2,5-di-tertbuthyl-benzohydroquinone 10 mM in standard external medium containing (in mM): NaCl, 145; KCl, 5; MgCl 2 , 1; glucose, 10; HEPES, 10, pH 7.4, supplemented with 0.5 mM EGTA. Cells were then washed and incubated for 1 h at room temperature in the same medium with 1 mM coelenterazine n. In some experiments, 10 mM EGTA-acetoxymethyl ester (EGTA-AM) was also added during this period to load the cells with a Ca 2 þ chelator. Then, the coverslip was placed in the perfusion chamber of a purpose-built luminometer (see above), and standard medium containing 0.5 mM EGTA was perfused for 5 min before the experiment. Calibration of the luminescence data into [Ca 2 þ ] was made using an algorithm as described previously (Montero et al., 2002) .
Measurement of mitochondrial membrane potential
Mitochondrial membrane potential was monitored using the fluorescent indicator tetramethylrhodamine ethyl ester (TMRE). HeLa cells were placed in the cell chamber, permeabilized as described above and then perfused with intracellular medium containing 20nM TMRE until a steadystate fluorescence was reached (usually about 5 min). Single cell fluorescence was excited at 540 nm using a Cairn monochromator (200 ms excitation every 2 s) and images of the fluorescence emitted between 570 and 630 nm obtained with a Â 40 Fluar objective were recorded by a Hamamatsu ORCA-ER camera. Single cell fluorescence records were analyzed off-line using the Metafluor program (Universal Imaging, Photometrics UK, Marlow, Buckinghamshire, UK). Experiments were performed at 371C using an online heater (Harvard Apparatus, Holliston, MA, USA).
Fura-2 loaded HeLa cells were used for these measurements. Although this dye may distribute heterogeneously in different intracellular compartments, including ER and mitochondria, it is known to reflect mainly the behavior of the [Ca 2 þ ] in the cytosolic compartment. In HeLa cells in particular, both fura-2 and cytosolic aequorin have been shown to report similar histamine-induced [Ca 2 þ ] peaks , and abolition of mitochondrial Ca 2 þ uptake with a protonophore produced little changes in the histamine-induced [Ca 2 þ ] peak monitored with fura-2 (Rizzuto et al., 1994) . HeLa cells were loaded with fura-2 by incubation in standard medium containing 2 mM fura-2-AM for 45 min at room temperature. Cells were then washed with standard medium for 45 min at room temperature and mounted in a cell chamber on the stage of a Zeiss Axiovert 200 microscope (Carl Zeiss Inc., Thornwood, NY, USA) under continuous perfusion. Single cell fluorescence was excited at 340 and 380 nm using a Cairn monochromator (100 ms excitation at each wavelength every 2 s, 10 nm bandwidth) and images of the emitted fluorescence obtained with a Â 40 Fluar objective were collected using a 400DCLP dichroic mirror and a D510/80 emission filter (both from Chroma Technology Corp., Rockingham, VT, USA) and recorded by a Hamamatsu ORCA-ER camera (Hamamatsu Photonics KK, Hamamatsu City, Shizuoka Pref., Japan). Single cell fluorescence records were ratioed and calibrated into [Ca 2 þ ] values off-line as described before (Grynkiewicz et al., 1985) using the Metafluor program (Universal Imaging). Experiments were performed at 371C using an on-line heater (Harvard Apparatus). 
Data analysis

Results
Inhibition by KB-R7943 of the MCU In Figure 1, was not owing to mitochondrial depolarization. KB-R7943 inhibits mitochondrial Cacollapsed membrane potential. On the other hand, as KB-R7943 is known to inhibit the plasma membrane NCX, we have also tested if the mitochondrial NCX system is sensitive to this inhibitor. Figure 3 shows (Collins et al., 2000) and shows that a selective inhibition of MCU, in the absence of mitochondrial depolarization, produces the same results. Collins et al. (2000) also showed that protonophores reversibly abolish histamine-induced cytosolic Ca 2 þ oscillations. We then decided to study if selective inhibition of MCU could also produce the same results. That was the case, as shown in Figure 6a where 10 Figure 1 . Figure 6b shows that 5 mM KB-R7943 (concentration producing half-maximal inhibition of MCU) only partially blocked oscillations. In a series of 326 analyzed cells, 5 mM KB-R7943 completely blocked oscillations in 132 (40%), whereas 10 mM KB-R7943 completely abolished oscillations in 261 of 306 analyzed cells treated with this concentration of the inhibitor (85%). In these cells, the oscillatory behavior remained blocked for as long as the inhibitor was present (up to 20 min in some experiments, data not shown) and reappeared rapidly when it was washed out. The rest of the analyzed cells treated with 5 or 10 mM KB-R7943 showed in any case a clear decrease in the oscillatory frequency. Interestingly, KB-R7943 concentrations below 5 mM did not block oscillations but still produced some subtle effects on the oscillatory pattern. Figure 6c shows that 2 mM KB-R-7943 induced a transient decrease in the frequency of the oscillations immediately after addition of the compound. Then, after a couple of minutes, the oscillatory frequency recovered even though KB-R7943 was still present. This recovery was probably an adaptation of the oscillatory mechanism to the new situation because, when the compound was washed out, there was an immediate burst of activity before turning back to the original pattern.
Discussion
We describe in this paper a new target for KB-R7943 in the MCU. This compound was originally developed as an inhibitor of the plasma membrane NCX (Iwamoto et al., 1996) , and was in fact the starting compound of a family of inhibitors of this exchange system which are being explored for their possible cardioprotective efficacy in cardiac ischemia-reperfusion injury (Matsuda et al., 2001; Iwamoto, 2004; Iwamoto and Kita, 2004; Hagihara et al., 2005; Matsunaga et al., 2005) . We show here that KB-R7943 is also a potent inhibitor of the MCU at concentrations similar to those required for the inhibition of the plasma membrane NCX. This new target may be relevant in interpreting its effects in cardioprotection and ischemia-reperfusion injury. In fact, ischemia-reperfusion injury has been widely shown to involve mitochondrial Ca 2 þ overload and opening of the permeability transition pore (for reviews see Halestrap, 2006; Di Lisa and Bernardi, 2006; Vercesi et al., 2006) . Thus, inhibition by KB-R7943 of the MCU may block the increase in [Ca 2 þ ] M and the subsequent opening of the permeability transition pore. The inhibitory effect of KB-R7943 on mitochondrial Ca 2 þ uptake could also be useful in exploring the role of mitochondrial Ca 2 þ uptake in global cell Ca 2 þ homeostasis.
However, KB-R7943 is not very specific. In addition to its effects on the plasma membrane NCX, KB-R7943 inhibits other plasma membrane channels and transporters, such as NMDA, K þ , Na þ and Ca 2 þ channels (Sobolevsky and Khodorov, 1999; Matsuda et al., 2001; Tanaka et al., 2002) and the nicotinic acetylcholine receptor (Pintado et al., 2000) . Most of these channels and transporters, however, are only present in excitable cells, so that the only remaining target in many non-excitable cells (such as the HeLa cells used in this paper) appears to be the MCU. In addition, KB-R7943 is the first available inhibitor of the MCU, which is freely permeable through the plasma membrane. Up to now, the only MCU inhibitors known were Ruthenium Red and Ru360 (Bernardi, 1999) , two compounds with very low permeability through the plasma membrane. Thus, the only way to investigate the effects of mitochondrial Ca 2 þ uptake on Ca 2 þ dynamics in intact cells was to use protonophores or inhibitors of the electron-transport chain. KB-R7943 now provides a possibility of investigating in non-excitable cells, the effect of inhibiting mitochondrial Ca 2 þ uptake in the absence of mitochondrial depolarization and other nonspecific effects of those drugs. We have used this property here to study the effect of inhibiting MCU on ER-Ca 2 þ release and histamine-induced oscillations (Collins et al., 2000) . We show here that the same findings can be obtained simply by inhibiting MCU with KB-R7943. The conclusion is that MCU is a key controller of InsP 3 -induced Ca 2 þ release. obtained by that maneuver was just enough to activate InsP 3 R in these cells . In HeLa cells, in contrast, we have shown that feedback Ca 2 þ inhibition is a major factor responsible for blocking histamine-induced Ca 2 þ release (Montero et al., 1997) . This may explain why in these cells blocking MCU leads to a faster block of Ca 2 þ release. It is interesting to also note that MCU block led to a prolonged (at least 10-20 min) and rapidly reversible inhibition of cytosolic Ca 2 þ oscillations induced by histamine.
This effect can be explained as a rapid feedback Ca 2 þ inhibition of local InsP 3 R (due to the absence of mitochon- Then, when the inhibitor is washed out, these local Ca 2 þ signals would be immediately enhanced, thus restoring the oscillatory activity. The overshoot of oscillatory activity observed in many cells at that moment could be due to the higher Ca 2 þ content of the ER, which would be full because of the absence of previous releasing activity. Then, when periodic oscillations are again established, the mean Ca 2 þ content of the ER is reduced (Ishii et al., 2006; Vay et al., 2007) and cells return to the original activity. In summary, our results show that the interplay between mitochondria and ER controlling the activation of InsP 3 R is a key factor responsible for the generation of Ca 2 þ oscillations. level, the rate of energy production and the opening of the permeability transition pore. Development of specific drugs targeted to these fluxes may be potentially useful as new pharmacological tools in the future.
